Subjects with familial hypercholesterolemia are characterized by an inflammatory phenotype despite long-term intensive cholesterol lowering treatment-Reference-Cited by-同舟云学术

Subjects with familial hypercholesterolemia are characterized by an inflammatory phenotype despite long-term intensive cholesterol lowering treatment

Published:2014-04 Issue:2 Volume:233 Page:561-567
ISSN:0021-9150
Container-title:Atherosclerosis
language:en
Short-container-title:Atherosclerosis

Author:

Holven Kirsten B.,Narverud Ingunn,Lindvig Henriette W.,Halvorsen Bente,Langslet Gisle,Nenseter Marit S.,Ulven Stine M.,Ose Leiv,Aukrust Pål,Retterstøl Kjetil^ORCID

Funder

Norwegian Association of Heart and Lung Patients

The Throne Holst Foundation for Nutrition Research

Freia Chocolade Fabriks Medical Foundation

Johan H. Andresen Medical Foundation

University of Oslo

Nordic Center of Excellence

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference36 articles.

1. Diet, nutrition and the prevention of chronic diseases: report of a Joint WHO/FAO Expert Consultation,2003

2. The immune system in atherosclerosis;Hansson;Nat Immunol,2011

3. Tumor necrosis factor superfamily molecules in acute coronary syndromes;Aukrust;Ann Med,2011

4. CD40 signaling and plaque instability;Schönbeck;Circ Res,2001

5. CD137 (4-1BB) deficiency reduces atherosclerosis in hyperlipidemic mice;Jeon;Circulation,2010

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ocular manifestations of severe familial hypercholesterolemia;Heliyon;2024-05

2. Gene expression profiling in elderly patients with familial hypercholesterolemia with and without coronary heart disease;Atherosclerosis;2024-05

3. Plasma legumain in familial hypercholesterolemia: associations with statin use and cardiovascular risk markers;Scandinavian Journal of Clinical and Laboratory Investigation;2024-02

4. Efficacy of Poria cocos and Alismatis rhizoma against diet-induced hyperlipidemia in rats based on transcriptome sequencing analysis;Scientific Reports;2023-10-15

5. Barriers and shortcomings in access to cardiovascular management and prevention for familial hypercholesterolemia during the COVID‐19 pandemic;Clinical Cardiology;2023-06